0001091596-18-000002.txt : 20180612 0001091596-18-000002.hdr.sgml : 20180612 20180612153140 ACCESSION NUMBER: 0001091596-18-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180612 DATE AS OF CHANGE: 20180612 EFFECTIVENESS DATE: 20180612 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nuo Therapeutics, Inc. CENTRAL INDEX KEY: 0001091596 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 233011702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-314431 FILM NUMBER: 18894376 BUSINESS ADDRESS: STREET 1: 207A PERRY PARKWAY, STREET 2: SUITE 1 CITY: GAITHERSBURG, STATE: MD ZIP: 20877 BUSINESS PHONE: 240-499-2680 MAIL ADDRESS: STREET 1: 207A PERRY PARKWAY, STREET 2: SUITE 1 CITY: GAITHERSBURG, STATE: MD ZIP: 20877 FORMER COMPANY: FORMER CONFORMED NAME: Nuo Therapeutics, Inc DATE OF NAME CHANGE: 20141112 FORMER COMPANY: FORMER CONFORMED NAME: CYTOMEDIX INC DATE OF NAME CHANGE: 20000511 FORMER COMPANY: FORMER CONFORMED NAME: AUTOLOGOUS WOUND THERAPY INC DATE OF NAME CHANGE: 20000407 D 1 primary_doc.xml X0708 D LIVE 0001091596 Nuo Therapeutics, Inc. 207A PERRY PARKWAY, SUITE 1 GAITHERSBURG, MD MARYLAND 20877 240-499-2680 DELAWARE Informatix Holdings, Inc. Nuo Therapeutics, Inc CYTOMEDIX INC AUTOLOGOUS WOUND THERAPY INC Corporation true DAVID E JORDEN 207A PERRY PARKWAY SUITE 1 GAITHERSBURG MD MARYLAND 20877 Executive Officer Director PAUL D MINTZ 207A PERRY PARKWAY SUITE 1 GAITHERSBURG MD MARYLAND 20877 Director ERIC C WINZER 207A PERRY PARKWAY SUITE 1 GAITHERSBURG MD MARYLAND 20877 Director SCOTT M PITTMAN 207A PERRY PARKWAY SUITE 1 GAITHERSBURG MD MARYLAND 20877 Director LAWRENCE S ATINSKY 207A PERRY PARKWAY SUITE 1 GAITHERSBURG MD MARYLAND 20877 Director PETER A CLAUSEN 207A PERRY PARKWAY SUITE 1 GAITHERSBURG MD MARYLAND 20877 Executive Officer Biotechnology Decline to Disclose 06b false 2018-05-28 false true false 500000 500000 500000 0 false 1 0 0 0 false Nuo Therapeutics, Inc. /S/ DAVID E. JORDEN DAVID E. JORDEN CEO AND CFO 2018-06-12